Managers / Q2 2021 · view latest →
Gates Foundation
CIK 0001663801 · 500 5TH AVE NORTH, SEATTLE, WA, 98109 · 206-709-3100
Summary
Gates Foundation reported $692M in U.S.-listed holdings across 8 positions for Q2 2021.
The portfolio is heavily concentrated: BNTX alone accounts for 33.7% of reported value.
Compared with Q1 2021, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ADR · 42.9% · $297M
- Other · 33.2% · $230M
- Common Stock · 23.8% · $165M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ZYUSDZYMERGEN INC | NEW | +60.0K | 60.0K | +$2M | $2M |
| BNTXBIONTECH SE | HELD | +0 | 1.04M | +$120M | $233M |
| CUREVAC N V | HELD | +0 | 3.13M | −$57M | $230M |
| VIRVIR BIOTECHNOLOGY INC | HELD | +0 | 2.78M | −$11M | $131M |
| ATRECA INC | HELD | +0 | 1.40M | −$9M | $12M |
| IMCRIMMUNCORE HLDGS PLC | HELD | +0 | 1.63M | −$5M | $64M |
| BFLYBUTTERFLY NETWORK INC | HELD | +0 | 1.01M | −$2M | $15M |
| AMYRIS INC | HELD | +0 | 292.4K | −$785,000 | $5M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | BNTXBIONTECH SEhistory → | SPONSORED ADS | 33.68% | $233M | 1.04M |
| 2 | CUREVAC N V | COM | 33.25% | $230M | 3.13M |
| 3 | VIRVIR BIOTECHNOLOGY INChistory → | COM | 18.94% | $131M | 2.78M |
| 4 | IMCRIMMUNCORE HLDGS PLChistory → | ADS | 9.25% | $64M | 1.63M |
| 5 | BFLYBUTTERFLY NETWORK INChistory → | CL A COM | 2.17% | $15M | 1.01M |
| 6 | ATRECA INC | CL A COM | 1.73% | $12M | 1.40M |
| 7 | AMYRIS INC | COM NEW | 0.69% | $5M | 292.4K |
| 8 | ZYUSDZYMERGEN INC | COM | 0.29% | $2M | 60.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $44M | 5 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $60M | 6 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $84M | 8 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $90M | 8 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $84M | 9 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $126M | 9 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $113M | 9 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $130M | 9 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $127M | 10 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $130M | 9 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $186M | 11 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $330M | 11 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $342M | 10 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $692M | 8 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $656M | 7 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $438M | 5 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.